Isoquercitrin

Research use only, not for human use.

Isoquercitrin is a potential stimulator of bone mineralization used for prophylaxis of osteoporotic disorders.

Isoquercitrin is a potential stimulator of bone mineralization used for prophylaxis of osteoporotic disorders. Isoquercitrin may be as a potential therapeutic agent against neurodegeneration in Parkinson's disease. Isoquercitrin is an inhibitor of Wnt/β-catenin and may be as a potential novel anti-tumoral agent, such as against human pancreati、 liver cancer related to opioid receptors and to the activation of the mitogen-activated protein kinase (MAPK) signalling pathway. .

Cell Viability Assay Cell Line:HepG2 cells Concentration:5 μM, 10 μM, 20 μM Incubation Time:24 hours Result:Caused significantly enhanced cell viability as positive controls.Western Blot Analysis Cell Line:HepG2 cells Concentration:10 μM Incubation Time:1 hour Result:Decreased ethanol‐ induced iNOS protein expression.

——

——

Others

Antioxidant

Wnt/β-catenin

Others-Field

——

482-35-9

464.37

C21H20O12

>98% (HPLC)

In Vitro:?DMSO : 19.23 mg/mL (41.41 mM)

C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O

——

(-20℃)

With Ice Pack

≥ 2 years